{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:12:16Z","timestamp":1790698336365,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["ASAP- 020600"],"award-info":[{"award-number":["ASAP- 020600"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["ASAP-000463"],"award-info":[{"award-number":["ASAP-000463"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["ASAP- 020600"],"award-info":[{"award-number":["ASAP- 020600"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["ASAP- 020600"],"award-info":[{"award-number":["ASAP- 020600"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG089563"],"award-info":[{"award-number":["R21AG089563"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS119690"],"award-info":[{"award-number":["R01NS119690"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aligning Science Across Parkinson's through the Michael J. Fox Foundation for Parkinson's Research"},{"name":"Research Frontiers Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is defined pathologically by loss of dopamine-producing neurons in the substantia nigra pars compacta (SNc). Yet synaptic dysfunction emerges much earlier, making it essential to define the mechanisms that drive early nigrostriatal deregulation. In the SNc, molecularly distinct dopamine neuron subtypes show differential susceptibility to PD. Here, we used intersectional genetic mouse models to determine how the PD-linked kinase LRRK2 affects vulnerable dopamine subtypes. Immunofluorescence and proximity-labeling proteomics revealed enriched LRRK2 expression in vulnerable dopamine neuron subclusters. High-resolution imaging showed that pathogenic LRRK2 disrupts presynaptic release-site organization in vulnerable dopamine axons, leading to reduced spontaneous and evoked striatal dopamine release in vivo. Proteomic analyses further showed that mutant LRRK2 increases phosphorylation of RAB3 proteins, impairing their interaction with the active-zone effectors RIM1 and RIM2. Together, these findings highlight a subtype-specific, cell-autonomous mechanism by which pathogenic LRRK2 impairs PD-vulnerable nigrostriatal synapses and provide a framework for therapeutic strategies targeting early synaptic deficits in PD.<\/jats:p>","DOI":"10.1038\/s41467-026-75194-3","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:38:25Z","timestamp":1785245905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leucine-rich repeat kinase 2 impairs the release sites of Parkinson\u2019s disease vulnerable dopamine axons"],"prefix":"10.1038","volume":"17","author":[{"given":"Chuyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Tombesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1536-435X","authenticated-orcid":false,"given":"Matthew","family":"Jaconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1378-2545","authenticated-orcid":false,"given":"Oscar Andr\u00e9s","family":"Moreno-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Serio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahaira","family":"Naaldijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-6232","authenticated-orcid":false,"given":"Vanessa","family":"Promes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4141-6064","authenticated-orcid":false,"given":"Amanda","family":"Schneeweis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nasios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-3598","authenticated-orcid":false,"given":"Elisa","family":"Greggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3710-1484","authenticated-orcid":false,"given":"Yevgenia","family":"Kozorovitskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-830X","authenticated-orcid":false,"given":"Daniel","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir R.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2140-9185","authenticated-orcid":false,"given":"Dario R.","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2576-5918","authenticated-orcid":false,"given":"Daniel A.","family":"Dombeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Hilfiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-2140","authenticated-orcid":false,"given":"Rajeshwar","family":"Awatramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2569-4200","authenticated-orcid":false,"given":"Loukia","family":"Parisiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"75194_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s Disease. Brain 122, 1437\u20131448 (1999).","journal-title":"Brain"},{"key":"75194_CR2","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley, J. M. & Lees, A. J. Ageing and Parkinson\u2019s Disease: substantia nigra regional selectivity. Brain 114, 2283\u20132301 (1991).","journal-title":"Brain"},{"key":"75194_CR3","doi-asserted-by":"crossref","unstructured":"Sulzer, D. & Surmeier, D. J. Neuronal vulnerability, pathogenesis, and Parkinson\u2019s Disease. Mov. Disord. 28, 41\u201350 (2013).","DOI":"10.1002\/mds.25095"},{"key":"75194_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish, S. J., Shannak, K. & Hornykiewicz, O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s Disease. N. Engl. J. Med. 318, 876\u2013880 (1988).","journal-title":"N. Engl. J. Med."},{"key":"75194_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jchemneu.2016.02.001","volume":"76","author":"YH Fu","year":"2016","unstructured":"Fu, Y. H., Paxinos, G., Watson, C. & Halliday, G. M. The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration. J. Chem. Neuroanat. 76, 98\u2013107 (2016).","journal-title":"J. Chem. Neuroanat."},{"key":"75194_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.54.5.388","volume":"54","author":"WRG Gibb","year":"1991","unstructured":"Gibb, W. R. G. & Lees, A. J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson\u2019s Disease. J. Neurol. Neurosurg. Psychiatry 54, 388\u2013396 (1991).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"75194_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.celrep.2014.10.008","volume":"9","author":"JF Poulin","year":"2014","unstructured":"Poulin, J. F. et al. Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling. Cell Rep. 9, 930\u2013943 (2014).","journal-title":"Cell Rep."},{"key":"75194_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.09.027","volume":"167","author":"G La Manno","year":"2016","unstructured":"La Manno, G. et al. Molecular diversity of midbrain development in mouse, human, and stem cells. Cell 167, 566\u2013580.e19 (2016).","journal-title":"Cell"},{"key":"75194_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2018.07.028","volume":"174","author":"A Saunders","year":"2018","unstructured":"Saunders, A. et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell 174, 1015\u20131030.e16 (2018).","journal-title":"Cell"},{"key":"75194_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.celrep.2019.06.095","volume":"28","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Distinct connectivity and functionality of aldehyde dehydrogenase 1a1-positive nigrostriatal dopaminergic neurons in motor learning. Cell Rep. 28, 1167\u20131181.e7 (2019).","journal-title":"Cell Rep."},{"key":"75194_CR11","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1172\/JCI72176","volume":"124","author":"G Liu","year":"2014","unstructured":"Liu, G. et al. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation. J. Clin. Investig. 124, 3032\u20133046 (2014).","journal-title":"J. Clin. Investig."},{"key":"75194_CR12","doi-asserted-by":"publisher","unstructured":"Pereira Luppi, M. et al. Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins. Cell Rep. 37, 109975 https:\/\/doi.org\/10.1016\/j.celrep.2021.109975 (2021).","DOI":"10.1016\/j.celrep.2021.109975"},{"key":"75194_CR13","doi-asserted-by":"publisher","unstructured":"Azcorra, M. et al, Unique functional responses differentially map onto genetic subtypes of dopamine neurons. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-023-01401-9 (2023).","DOI":"10.1038\/s41593-023-01401-9"},{"key":"75194_CR14","doi-asserted-by":"publisher","unstructured":"Mantas, I. et al. Anxa1+ dopamine neuron vulnerability defines prodromal Parkinson\u2019s Disease bradykinesia and procedural motor learning impairment. December 22, https:\/\/doi.org\/10.1101\/2024.12.22.629963 (2024).","DOI":"10.1101\/2024.12.22.629963"},{"key":"75194_CR15","doi-asserted-by":"publisher","unstructured":"Fushiki, A. et al. A vulnerable subtype of dopaminergic neurons drives early motor deficits in Parkinson\u2019s Disease. bioRxiv https:\/\/doi.org\/10.1101\/2024.12.20.629776 (2024).","DOI":"10.1101\/2024.12.20.629776"},{"key":"75194_CR16","doi-asserted-by":"publisher","unstructured":"Hadjas, L. C. et al. Parkinson\u2019s Disease-vulnerable and -resilient dopamine neurons display opposite responses to excitatory input. https:\/\/doi.org\/10.1101\/2025.06.03.657460 (2025).","DOI":"10.1101\/2025.06.03.657460"},{"key":"75194_CR17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41593-018-0203-4","volume":"21","author":"JF Poulin","year":"2018","unstructured":"Poulin, J. F. et al. Mapping projections of molecularly defined dopamine neuron subtypes using intersectional genetic approaches. Nat. Neurosci. 21, 1260\u20131271 (2018).","journal-title":"Nat. Neurosci."},{"key":"75194_CR18","doi-asserted-by":"publisher","unstructured":"Surmeier, D. J. et al, Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s Disease. https:\/\/doi.org\/10.3389\/fncel.2021.626128 (2021).","DOI":"10.3389\/fncel.2021.626128"},{"key":"75194_CR19","doi-asserted-by":"crossref","unstructured":"Wong, Y. C. et al. Neuronal vulnerability in Parkinson Disease: should the focus be on axons and synaptic terminals? Mov. Disord. 34, 1406\u20131422 (2012).","DOI":"10.1002\/mds.27823"},{"key":"75194_CR20","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower, J. H. et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s Disease. Brain 136, 2419\u20132431 (2013).","journal-title":"Brain"},{"key":"75194_CR21","doi-asserted-by":"publisher","unstructured":"Cramb, K. M. L., Beccano-Kelly, D., Cragg, S. J. & Wade-3 Martins, R. Impaired dopamine release in Parkinson\u2019s Disease 2 here we review the evidence for dopamine release deficits prior to neurodegeneration In. https:\/\/doi.org\/10.1093\/brain\/awad064\/7067886 (2023).","DOI":"10.1093\/brain\/awad064\/7067886"},{"key":"75194_CR22","doi-asserted-by":"publisher","unstructured":"Leonard, H. L. Novel Parkinson\u2019s Disease genetic risk factors within and across European populations. March 17, https:\/\/doi.org\/10.1101\/2025.03.14.24319455 (2025).","DOI":"10.1101\/2025.03.14.24319455"},{"key":"75194_CR23","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang, D. et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s Disease risk loci. Nat. Genet. 49, 1511\u20131516 (2017).","journal-title":"Nat. Genet."},{"key":"75194_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/humu.22372","volume":"34","author":"CE Krebs","year":"2013","unstructured":"Krebs, C. E. et al. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures. Hum. Mutat. 34, 1200\u20131207 (2013).","journal-title":"Hum. Mutat."},{"key":"75194_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ana.24553","volume":"79","author":"S Olgiati","year":"2016","unstructured":"Olgiati, S. et al. DNAJC6 mutations associated with early-onset Parkinson\u2019s Disease. Ann. Neurol. 79, 244\u2013256 (2016).","journal-title":"Ann. Neurol."},{"key":"75194_CR26","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrn2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson, M. R. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s Disease. Nat. Rev. Neurosci. 11, 791\u2013797 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"75194_CR27","doi-asserted-by":"crossref","unstructured":"Alessi, D. R.& Sammler, E. LRRK2 kinase in Parkinson\u2019s Disease. Science, pp 36\u201337 (American Association for the Advancement of Science, 2018).","DOI":"10.1126\/science.aar5683"},{"key":"75194_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tibs.2021.10.003","volume":"47","author":"V Tokars","year":"2022","unstructured":"Tokars, V., Chen, C. & Parisiadou, L. Closing the structure-to-function gap for LRRK2. Trends Biochem. Sci. 47, 187\u2013188 (2022).","journal-title":"Trends Biochem. Sci."},{"key":"75194_CR29","doi-asserted-by":"publisher","unstructured":"Di Maio, R. et al. LRRK2 Activation in Idiopathic Parkinson\u2019s Disease. Sci. Transl. Med. 10, 5459 https:\/\/doi.org\/10.1126\/scitranslmed.aar5429 (2018).","DOI":"10.1126\/scitranslmed.aar5429"},{"key":"75194_CR30","unstructured":"Jennings, D. et al. Preclinical and Clinical Evaluation of the LRRK2 Inhibitor DNL201 for Parkinson\u2019s Disease; Vol. 14. https:\/\/www.science.org (2022)."},{"key":"75194_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mds.29297","volume":"38","author":"D Jennings","year":"2023","unstructured":"Jennings, D. et al. LRRK2 inhibition by BIIB122 in healthy participants and patients with Parkinson\u2019s Disease. Mov. Disord. 38, 386\u2013398 (2023).","journal-title":"Mov. Disord."},{"key":"75194_CR32","doi-asserted-by":"crossref","unstructured":"Volta, M. & Melrose, H. LRRK2 mouse models: dissecting the behavior, striatal neurochemistry and neurophysiology of PD pathogenesis. Biochemical Society Transactions, pp. 113\u2013122 (Portland Press Ltd., 2017).","DOI":"10.1042\/BST20160238"},{"key":"75194_CR33","doi-asserted-by":"publisher","unstructured":"Chang, E. E. S. et al. LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson\u2019s Disease. Transl. Neurodegener. BioMed Central Ltd December 1, https:\/\/doi.org\/10.1186\/s40035-022-00285-2 (2022).","DOI":"10.1186\/s40035-022-00285-2"},{"key":"75194_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.nbd.2015.02.031","volume":"78","author":"M Yue","year":"2015","unstructured":"Yue, M. et al. Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol. Dis. 78, 172\u2013195 (2015).","journal-title":"Neurobiol. Dis."},{"key":"75194_CR35","doi-asserted-by":"publisher","unstructured":"Xenias, H. S. et al. R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations. Commun. Biol. 5, https:\/\/doi.org\/10.1038\/s42003-022-04136-8 (2022).","DOI":"10.1038\/s42003-022-04136-8"},{"key":"75194_CR36","doi-asserted-by":"publisher","first-page":"14622","DOI":"10.1073\/pnas.0906334106","volume":"106","author":"Y Tong","year":"2009","unstructured":"Tong, Y. et al. R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc. Natl. Acad. Sci. USA 106, 14622\u201314627 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75194_CR37","doi-asserted-by":"publisher","unstructured":"Tozzi, A. et al. Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson\u2019s Disease. Cell Death Dis. 9, https:\/\/doi.org\/10.1038\/s41419-017-0221-2 (2018).","DOI":"10.1038\/s41419-017-0221-2"},{"key":"75194_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nn.2349","volume":"12","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson\u2019s Disease. Nat. Neurosci. 12, 826\u2013828 (2009).","journal-title":"Nat. Neurosci."},{"key":"75194_CR39","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/cne.23583","volume":"522","author":"AB West","year":"2014","unstructured":"West, A. B. et al. Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents. J. Comp. Neurol. 522, 2465\u20132480 (2014).","journal-title":"J. Comp. Neurol."},{"key":"75194_CR40","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","volume":"32","author":"X Lin","year":"2012","unstructured":"Lin, X. et al. Conditional expression of Parkinson\u2019s Disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J. Neurosci. 32, 9248\u20139264 (2012).","journal-title":"J. Neurosci."},{"key":"75194_CR41","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1073\/pnas.1712648115","volume":"115","author":"Y Xiong","year":"2018","unstructured":"Xiong, Y. et al. Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proc. Natl. Acad. Sci. USA 115, 1635\u20131640 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75194_CR42","doi-asserted-by":"crossref","unstructured":"Steger, M. et al. Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. Elife 6, 31012 (2017).","DOI":"10.7554\/eLife.31012"},{"key":"75194_CR43","doi-asserted-by":"crossref","unstructured":"Steger, M. et al. Phosphoproteomics reveals that Parkinson\u2019s Disease kinase LRRK2 regulates a subset of Rab GTPases. Elife 5, 12813 (2016).","DOI":"10.7554\/eLife.12813"},{"key":"75194_CR44","doi-asserted-by":"crossref","unstructured":"Yamada, T., Mcgeer, P. L., Baimbridge, K. G. & Mcgeer, E. G. Relative sparing in Parkinson\u2019s Disease of substantia nigra dopamine neurons containing Calbindin-D2sK. Brain Res. 526, 303\u2013307 (1990).","DOI":"10.1016\/0006-8993(90)91236-A"},{"key":"75194_CR45","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nmeth.3179","volume":"12","author":"SS Lam","year":"2014","unstructured":"Lam, S. S. et al. Directed evolution of APEX2 for electron microscopy and proximity labeling. Nat. Methods 12, 51\u201354 (2014).","journal-title":"Nat. Methods"},{"key":"75194_CR46","doi-asserted-by":"crossref","unstructured":"Dumrongprechachan, V., Salisbury, R. B., Butler, L., Macdonald, M. L. & Kozorovitskiy, Y. Dynamic proteomic and phosphoproteomic atlas of corticostriatal axons in neurodevelopment. Elife 11, 78847 (2022).","DOI":"10.7554\/eLife.78847"},{"key":"75194_CR47","doi-asserted-by":"publisher","unstructured":"Dumrongprechachan, V., Soto, G., Macdonald, M. L. & Kozorovitskiy, Y. Cell type and subcellular compartment specific APEX2 proximity labeling proteomics in the mouse brain. https:\/\/doi.org\/10.1101\/2021.04.08.439091.","DOI":"10.1101\/2021.04.08.439091"},{"key":"75194_CR48","doi-asserted-by":"crossref","unstructured":"Hobson, B. D. et al. Subcellular proteomics of dopamine neurons in the mouse brain. Elife 11, 70921 (2022).","DOI":"10.7554\/eLife.70921"},{"key":"75194_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath, T. et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s Disease. Nat. Neurosci. 25, 588\u2013595 (2022).","journal-title":"Nat. Neurosci."},{"key":"75194_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.115.227587","volume":"355","author":"MJ Fell","year":"2015","unstructured":"Fell, M. J. et al. MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition. J. Pharmacol. Exp. Therapeutics 355, 397\u2013409 (2015).","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"75194_CR51","doi-asserted-by":"publisher","unstructured":"Kluss, J. H. et al. Preclinical modeling of chronic inhibition of the parkinson\u2019s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo. Mol. Neurodegener. 16, https:\/\/doi.org\/10.1186\/S13024-021-00441-8 (2021).","DOI":"10.1186\/S13024-021-00441-8"},{"key":"75194_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.58997","volume":"9","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations. Elife 9, 1\u201326 (2020).","journal-title":"Elife"},{"key":"75194_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-025-00257-6","author":"H He","year":"2025","unstructured":"He, H., Ai, R., Fang, E. F. & Palikaras, K. The Rab3 family proteins in age-related neurodegeneration: unraveling molecular pathways and potential therapeutic targets. npj Aging https:\/\/doi.org\/10.1038\/s41514-025-00257-6 (2025).","journal-title":"npj Aging"},{"key":"75194_CR54","doi-asserted-by":"crossref","unstructured":"Wang, Y. F. H., Okamoto, M., Schmitz, K. & S\u00fcdhof, T. Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion. Nature 388, 593\u2013598 (1997).","DOI":"10.1038\/41580"},{"key":"75194_CR55","doi-asserted-by":"crossref","unstructured":"Dhekne, H. S. et al. Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson\u2019s Disease-linked LRRK2 Kinase. Elife 12, 87098 (2023).","DOI":"10.7554\/eLife.87098"},{"key":"75194_CR56","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1523\/JNEUROSCI.3553-05.2006","volume":"26","author":"OM Schl\u00fcter","year":"2006","unstructured":"Schl\u00fcter, O. M., Basu, J., S\u00fcdhof, T. C. & Rosenmund, C. Rab3 superprimes synaptic vesicles for release: implications for short-term synaptic plasticity. J. Neurosci. 26, 1239\u20131246 (2006).","journal-title":"J. Neurosci."},{"key":"75194_CR57","doi-asserted-by":"publisher","unstructured":"Jenkins, M. L. et al. The substrate specificity of the human TRAPPII complex\u2019s rab-guanine nucleotide exchange factor activity. Commun. Biol. 3, https:\/\/doi.org\/10.1038\/s42003-020-01459-2 (2020).","DOI":"10.1038\/s42003-020-01459-2"},{"key":"75194_CR58","doi-asserted-by":"publisher","first-page":"e50416","DOI":"10.7554\/eLife.50416","volume":"8","author":"Kerryn Berndsen","year":"2019","unstructured":"Kerryn Berndsen et al. PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating rab proteins. Elife 8, e50416 (2019).","journal-title":"Elife"},{"key":"75194_CR59","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1042\/BCJ20190664","volume":"477","author":"S Vieweg","year":"2020","unstructured":"Vieweg, S. et al. PINK1-dependent phosphorylation of serine111 within the SF3 motif of rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at threonine72. Biochem. J. 477, 1651\u20131668 (2020).","journal-title":"Biochem. J."},{"key":"75194_CR60","doi-asserted-by":"publisher","unstructured":"Phung, T. K. et al. CURTAIN\u2014A unique web-based tool for exploration and sharing of MS-based proteomics data. Proc. Natl. Acad. Sci. USA. 121. https:\/\/doi.org\/10.1073\/pnas.2312676121 (2024).","DOI":"10.1073\/pnas.2312676121"},{"key":"75194_CR61","first-page":"46","volume-title":"Current Opinion in Neurobiology","author":"C Liu","year":"2019","unstructured":"Liu, C., Kaeser, P. S. Mechanisms and regulation of dopamine release. Current Opinion in Neurobiology. 146\u201353Elsevier Ltd: August, 2019)."},{"key":"75194_CR62","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.str.2020.01.005","volume":"28","author":"D Waschb\u00fcsch","year":"2020","unstructured":"Waschb\u00fcsch, D. et al. Structural basis for Rab8a recruitment of RILPL2 via LRRK2 phosphorylation of switch 2. Structure 28, 406\u2013417.e6 (2020).","journal-title":"Structure"},{"key":"75194_CR63","doi-asserted-by":"publisher","unstructured":"Dhekne, H. S. et al. A pathway for Parkinson\u2019s Disease LRRK2 kinase to block primary cilia and sonic hedgehog signaling in the brain. https:\/\/doi.org\/10.7554\/eLife.40202.001 (2018).","DOI":"10.7554\/eLife.40202.001"},{"key":"75194_CR64","doi-asserted-by":"publisher","unstructured":"Liu, C., Kershberg, L., Wang, J., Schneeberger, S. & Kaeser, P. S. Dopamine secretion is mediated by sparse active zone-like release sites. Cell https:\/\/doi.org\/10.1016\/j.cell.2018.01.008 (2018).","DOI":"10.1016\/j.cell.2018.01.008"},{"key":"75194_CR65","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nn.4252","volume":"19","author":"DB Pereira","year":"2016","unstructured":"Pereira, D. B. et al. Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum. Nat. Neurosci. 19, 578\u2013586 (2016).","journal-title":"Nat. Neurosci."},{"key":"75194_CR66","doi-asserted-by":"publisher","unstructured":"Ducrot, C. et al. Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals. FASEB J. 35, https:\/\/doi.org\/10.1096\/fj.202100201RR (2021).","DOI":"10.1096\/fj.202100201RR"},{"key":"75194_CR67","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuron.2021.10.028","volume":"110","author":"A Banerjee","year":"2022","unstructured":"Banerjee, A. et al. Molecular and functional architecture of striatal dopamine release sites. Neuron 110, 248\u2013265.e9 (2022).","journal-title":"Neuron"},{"key":"75194_CR68","unstructured":"Pylypenko, O. et al. Structure of rab escort protein-1 in complex with rab geranylgeranyltransferase transferase (RabGGTase). RabGGTase Is a Heterodimer Composed of Tightly Associated 68 KDa and 45 KDa Subunits and Belongs to the Family of Protein Prenyltrans-Ferases, Which Includes Farnesyl Transferase (FTase) and Geranylgeranyltransferase I (GGTaseI) (Casey and Sea; 2003; Vol. 11."},{"key":"75194_CR69","first-page":"365","volume":"2019","author":"JH Marshel","year":"1979","unstructured":"Marshel, J. H. et al. Cortical layer-specific critical dynamics triggering perception. Science 2019, 365 (1979).","journal-title":"Science"},{"key":"75194_CR70","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41592-023-02100-w","volume":"21","author":"Y Zhuo","year":"2024","unstructured":"Zhuo, Y. et al. Improved green and red GRAB sensors for monitoring dopaminergic activity in vivo. Nat. Methods 21, 680\u2013691 (2024).","journal-title":"Nat. Methods"},{"key":"75194_CR71","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature18942","volume":"535","author":"MW Howe","year":"2016","unstructured":"Howe, M. W. & Dombeck, D. A. Rapid signalling in distinct dopaminergic axons during locomotion and reward. Nature 535, 505\u2013510 (2016).","journal-title":"Nature"},{"key":"75194_CR72","doi-asserted-by":"crossref","unstructured":"Volta, M. et al. Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice. Elife 6, 28377 (2017).","DOI":"10.7554\/eLife.28377"},{"key":"75194_CR73","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1021\/acs.analchem.1c05123","volume":"94","author":"PT Kaulich","year":"2022","unstructured":"Kaulich, P. T., Cassidy, L., Winkels, K. & Tholey, A. Improved identification of proteoforms in top-down proteomics using FAIMS with internal CV stepping. Anal. Chem. 94, 3600\u20133607 (2022).","journal-title":"Anal. Chem."},{"key":"75194_CR74","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41592-024-02559-1","volume":"22","author":"JA Bubis","year":"2025","unstructured":"Bubis, J. A. et al. Challenging the Astral mass analyzer to quantify up to 5,300 proteins per single cell at unseen accuracy to uncover cellular heterogeneity. Nat. Methods 22, 510\u2013519 (2025).","journal-title":"Nat. Methods"},{"key":"75194_CR75","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.neuron.2016.07.005","volume":"91","author":"SSH Wang","year":"2016","unstructured":"Wang, S. S. H. et al. Fusion competent synaptic vesicles persist upon active zone disruption and loss of vesicle docking. Neuron 91, 777\u2013791 (2016).","journal-title":"Neuron"},{"key":"75194_CR76","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cell.2010.12.029","volume":"144","author":"PS Kaeser","year":"2011","unstructured":"Kaeser, P. S. et al. RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell 144, 282\u2013295 (2011).","journal-title":"Cell"},{"key":"75194_CR77","doi-asserted-by":"publisher","unstructured":"Leonard H. L. Global Parkinson\u2019s genetics program (GP2). Novel Parkinson\u2019s Disease genetic risk factors within and across European populations. medRxiv. https:\/\/doi.org\/10.1101\/2025.03.14.24319455 (2025).","DOI":"10.1101\/2025.03.14.24319455"},{"key":"75194_CR78","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","volume":"53","author":"G Liu","year":"2021","unstructured":"Liu, G. et al. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson\u2019s disease. Nat. Genet. 53, 787\u2013793 (2021).","journal-title":"Nat. Genet"},{"key":"75194_CR79","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/415321a","volume":"415","author":"S Schoch","year":"2002","unstructured":"Schoch, S. et al. RIM1a forms a protein scaffold for regulating neurotransmitter release at the active zone. Nature 415, 321\u2013326 (2002).","journal-title":"Nature"},{"key":"75194_CR80","doi-asserted-by":"crossref","unstructured":"S\u00fcdhof, T. C. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron. 80, 22 (2013).","DOI":"10.1016\/j.neuron.2013.10.022"},{"key":"75194_CR81","first-page":"1","volume":"0","author":"CM Persoon","year":"2019","unstructured":"Persoon, C. M. et al. The RAB3-RIM pathway is essential for the release of neuromodulators. Neuron 0, 1\u201316 (2019).","journal-title":"Neuron"},{"key":"75194_CR82","doi-asserted-by":"publisher","unstructured":"Dou, D., Aiken, J. & Holzbaur, E. L. F. RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors. J. Cell Biol. 223, 07092 https:\/\/doi.org\/10.1083\/jcb.202307092 (2024).","DOI":"10.1083\/jcb.202307092"},{"key":"75194_CR83","doi-asserted-by":"publisher","unstructured":"Skelton, P. D., Tokars, V. & Parisiadou, L. LRRK2 at striatal synapses: cell-type specificity and mechanistic insights. Cells 11, 169 https:\/\/doi.org\/10.3390\/CELLS11010169 (2022).","DOI":"10.3390\/CELLS11010169"},{"key":"75194_CR84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fnmol.2020.00153","volume":"13","author":"N Kuhlmann","year":"2020","unstructured":"Kuhlmann, N. & Milnerwood, A. J. A critical LRRK at the synapse? The neurobiological function and pathophysiological dysfunction of LRRK2. Front. Mol. Neurosci. 13, 153 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"75194_CR85","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nn.3636","volume":"17","author":"L Parisiadou","year":"2014","unstructured":"Parisiadou, L. et al. LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nat. Neurosci. 17, 367\u2013376 (2014).","journal-title":"Nat. Neurosci."},{"key":"75194_CR86","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1038\/s41380-025-03030-z","volume":"30","author":"C Chen","year":"2025","unstructured":"Chen, C. et al. LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons. Mol. Psychiatry 30, 4473\u20134486 (2025).","journal-title":"Mol. Psychiatry"},{"key":"75194_CR87","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.1523\/JNEUROSCI.3314-15.2016","volume":"36","author":"BA Matikainen-Ankney","year":"2016","unstructured":"Matikainen-Ankney, B. A. et al. Altered development of synapse structure and function in striatum caused by Parkinson\u2019s Disease-linked LRRK2-G2019S mutation. J. Neurosci. 36, 7128\u20137141 (2016).","journal-title":"J. Neurosci."},{"key":"75194_CR88","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng, H. C., Ulane, C. M. & Burke, R. E. Clinical progression in Parkinson disease and the neurobiology of axons. Ann. Neurol. 67, 715\u2013725 (2010).","journal-title":"Ann. Neurol."},{"key":"75194_CR89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke, R. E. & O\u2019Malley, K. Axon degeneration in Parkinson\u2019s disease. Exp. Neurol. 246, 72\u201383 (2013).","journal-title":"Exp. Neurol."},{"key":"75194_CR90","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1212\/01.wnl.0000335973.66333.58","volume":"71","author":"R Nandhagopal","year":"2008","unstructured":"Nandhagopal, R. et al. Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study. Neurology 71, 1790\u20131795 (2008).","journal-title":"Neurology"},{"key":"75194_CR91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","volume":"19","author":"T Simuni","year":"2020","unstructured":"Simuni, T. et al. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson\u2019s progression markers initiative (PPMI): a cross-sectional study. Lancet Neurol. 19, 71\u201380 (2020).","journal-title":"Lancet Neurol."},{"key":"75194_CR92","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41531-025-01004-0","volume":"11","author":"M Palanivel","year":"2025","unstructured":"Palanivel, M. et al. Imaging advances to detect non-motor prodromal markers of Parkinson\u2019s disease and explore therapeutic translation opportunities. npj Parkinsons Dis. 11, 174 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"75194_CR93","doi-asserted-by":"publisher","unstructured":"Janezic, S. et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl. Acad. Sci. USA. 110, 1309143110 https:\/\/doi.org\/10.1073\/pnas.1309143110 (2013).","DOI":"10.1073\/pnas.1309143110"},{"key":"75194_CR94","doi-asserted-by":"publisher","unstructured":"Vidyadhara, D. J. et al. Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson\u2019s Disease. Cell Rep. 42, 112231 https:\/\/doi.org\/10.1016\/j.celrep.2023.112231 (2023).","DOI":"10.1016\/j.celrep.2023.112231"},{"key":"75194_CR95","doi-asserted-by":"crossref","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 2019 (2012).","DOI":"10.1038\/nmeth.2019"},{"key":"75194_CR96","doi-asserted-by":"publisher","unstructured":"Bermejo, M. K., Milenkovic, M., Salahpour, A. & Ramsey, A. J. Preparation of synaptic plasma membrane and postsynaptic density proteins using a discontinuous sucrose gradient. J. Vis. Exp. 91, 51896 https:\/\/doi.org\/10.3791\/51896 (2014).","DOI":"10.3791\/51896"},{"key":"75194_CR97","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1074\/mcp.RA117.000314","volume":"16","author":"R Bruderer","year":"2017","unstructured":"Bruderer, R. et al. Optimization of experimental parameters in data-independent mass spectrometry significantly increases depth and reproducibility of results. Mol. Cell. Proteom. 16, 2296\u20132309 (2017).","journal-title":"Mol. Cell. Proteom."},{"key":"75194_CR98","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1021\/acs.jproteome.2c00122","volume":"21","author":"M Tognetti","year":"2022","unstructured":"Tognetti, M. et al. Biomarker candidates for tumors identified from deep-profiled plasma stem predominantly from the low abundant area. J. Proteome Res. 21, 1718\u20131735 (2022).","journal-title":"J. Proteome Res."},{"key":"75194_CR99","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/bioinformatics\/btab209","volume":"37","author":"JF Ouyang","year":"2021","unstructured":"Ouyang, J. F., Kamaraj, U. S., Cao, E. Y. & Rackham, O. J. L. ShinyCell: simple and sharable visualization of single-cell gene expression data. Bioinformatics 37, 3374\u20133376 (2021).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75194-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:03:29Z","timestamp":1787875409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75194-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75194"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75194-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9165"}}